AMIC to acquire Russian radioisotope developer

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

Advanced Medical Isotope Corporation (AMIC), a developer and distributor of medical isotopes, has engaged the Moscow-based Global TechInnovations (GTI) for assistance in acquiring a Russian company that specializes in the production and sales of radioactive isotopes used for medical diagnostic and therapeutic uses.

GTI also will assist in identifying and executing on further acquisition opportunities within Russia and the Former Soviet Union states. GTI will act as consultants and advisors to AMIC, providing services including participating in meetings and negotiations between AMIC and other target companies, as well as assisting in the post-acquisition support.

The Kennewick, Wash.-based AMIC said that the initial target company's assets include separation process technologies, analytical work product from multiple production and scientific partners, proprietary contracts and an existing global sales presence.